MedTrace Logo

Energy Availability in Female Athletes

NCT03593382 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 49

Last updated 2018-07-20

No results posted yet for this study

Summary

The purpose of this project is to study the impact of energy availability (EA) on female endurance athletes and the adaptive consequences of insufficient EA with a special reference to the impact on energy metabolism, reproductive-, vascular- and bone health as well as exercise capacity, neuromuscular performance, ability to recover from intense exercise and the genetic interaction.

Specific aims:

* To investigate the effects of EA on energy metabolism
* To investigate the effects of EA on reproductive, vascular- and bone health, and endocrine functions
* To investigate the effects of EA on exercise capacity
* To investigate the effects of EA on neuromuscular performance
* To investigate the effects of EA on recovery after exercise
* To identify potential dietary factors influencing EA, exercise capacity and neuromuscular performance
* To identify potential exercise factors influencing EA, exercise capacity and neuromuscular performance
* To identify potential psychological, behavoural and motivational aspects associated with insufficient EA

The investigators hypothesize that female athletes with insufficient energy availability have attenuated energy metabolism, reduced BMD, impaired endothelial function and decreased ability to recover between exercise bouts compared to matched controls with sufficient energy and nutrient intake. The investigators also hypothesize that EA influences exercise capacity and neuromuscular performance.

Conditions

  • Female Athlete Triad

Sponsors & Collaborators

  • Lund University

    collaborator OTHER

  • Herlev Hospital

    collaborator OTHER

  • University of Copenhagen

    lead OTHER

Principal Investigators

  • Anders sjödin, Assoc prof · Department of Human Nutrition, University of Copenhagen

Eligibility

Min Age
18 Years
Max Age
39 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2013-06-30
Completion
2013-12-31

Countries

  • Denmark
  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03593382 on ClinicalTrials.gov